Integra Lifesciences Holdings Corp

NASDAQ: IART    
Share price (5/2/24): $28.75    
Market cap (5/2/24): $2.260 billion
Search in Documents
Key Exhibits
External Links
4 Integra Lifesciences Holdings Corp Expert Interviews, now on BamSEC.
 Powered by Tegus.

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1C
from 10-K 29 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1B
from 10-K 131 pages Agreement and Plan of Merger by and Among Integra Lifesciences Holdings Corporation; Ils Ocean 12-20 Corp.; Acell, Inc.; and Fortis Advisors LLC, as the Security Holders’ Representative Dated as of December 15, 2020
12/34/56
EX-2.1
from 10-Q 105 pages To: The Sellers (As Defined in the Psa) Private and Confidential
12/34/56
EX-2.1
from 10-Q 66 pages Asset Purchase Agreement Dated as of September 8, 2017 by and Among Integra Lifesciences Holdings Corporation, Integra Lifesciences Corporation Integra Lifesciences Sales LLC, Integra Lifesciences (Ireland) Limited, Integra Neurosciences Implants (France) Sas, Integra Lifesciences Services (France) Sas, Integra Neurosciences Limited, Integra Lifesciences Italy S.R.L, Integra Gmbh, Integra Ls (Benelux) NV, Integra Canada Ulc Integra CI Inc. as the Sellers and Natus Medical Incorporated, as Buyer
12/34/56
EX-2.1
from 8-K 114 pages Asset Purchase Agreement Between Depuy Synthes, Inc. and Integra Lifesciences Holdings Corporation Dated as of February 14, 2017
12/34/56
EX-2.1
from 8-K 122 pages February 14, 2017 to the Attention Of: Depuy Synthes, Inc. 700 Orthopaedic Drive Warsaw, in 46581 Re: Final Binding Offer Ladies and Gentlemen
12/34/56
EX-2.1
from 8-K 84 pages Agreement and Plan of Merger by and Among Integra Lifesciences Holdings Corporation, Integra Derma, Inc. and Derma Sciences, Inc. Dated as of January 10, 2017
12/34/56
EX-2.1
from SC TO-C 84 pages Agreement and Plan of Merger by and Among Integra Lifesciences Holdings Corporation, Integra Derma, Inc. and Derma Sciences, Inc. Dated as of January 10, 2017
12/34/56
EX-2.2
from 8-K 72 pages Agreement and Plan of Merger by and Among Integra Lifesciences Corporation as “Parent” Patriot S2, Inc. as “Merger Sub Med” Tei Medical Inc. (“Tei Med”) and Dr. Yiannis Monovoukas as the “Sh Rep” Dated as of June 26, 2015
12/34/56
EX-2.1
from 8-K 74 pages Agreement and Plan of Merger by and Among Integra Lifesciences Corporation as “Parent” Patriot S1, Inc. as “Merger Sub Bio” Tei Biosciences Inc. (“Tei Bio”) and Dr. Yiannis Monovoukas as the “Sh Rep” Dated as of June 26, 2015
12/34/56
EX-2.1
from 8-K 43 pages Separation and Distribution Agreement by and Between Integra Lifesciences Holdings Corporation and Seaspine Holdings Corporation Dated as of June 30, 2015
12/34/56
EX-2.1
from 8-K 73 pages Stock and Asset Purchase Agreement by and Among Medtronic, Inc., Medtronic Xomed Instrumentation, Sas, and Integra Lifesciences Corporation, Dated as of September 12, 2014
12/34/56
EX-2.2
from 8-K ~50 pages Purchase Agreement
12/34/56
EX-2.1
from 8-K ~20 pages Asset Purchase Agreement
12/34/56
EX-2
from 8-K ~50 pages Asset Purchase Agreement
12/34/56
EX-2
from 8-K ~50 pages Asset Purchase Agreement
12/34/56
EX-2
from 8-K ~10 pages Purchase Agreement
12/34/56
EX-2
from 8-K ~50 pages Agreement and Plan of Merger
12/34/56